Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | Can WGS and RNAseq replace conventional first-line diagnostics for acute leukemia?

Richard Rosenquist • 23 Jun 2020
EHA 2020
Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Leukemia

Richard Rosenquist Brandell, MD, of Karolinska Institute, Solna, Stockholm, discusses a study by Genomic Medicine Sweden evaluating whether whole genome sequencing (WGS) and RNA sequencing (RNAseq) can replace conventional first-line clinical diagnostic methods for acute leukemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Explore the AML Channel banner with headshots of Naval Daver, Eunice Wang, and Thomas Cluzeau

More from Richard Rosenquist

How has the harmonization of genomic profiling in Sweden impacted patient access to CLL diagnostics?
1:21
How has the harmonization of genomic profiling in Sweden impacted patient access to CLL diagnostics?
Richard Rosenquist • 17 Oct 2026
Biological profiling in CLL: which emerging markers are changing management?
1:31
Biological profiling in CLL: which emerging markers are changing management?
Richard Rosenquist • 17 Oct 2026
Therapy-driven clonal dynamics in CLL: should clinicians repeat genomic profiling?
1:18
Therapy-driven clonal dynamics in CLL: should clinicians repeat genomic profiling?
Richard Rosenquist • 17 Oct 2026
The advancements and remaining challenges in precision medicine for CLL
2:09
The advancements and remaining challenges in precision medicine for CLL
Richard Rosenquist • 27 Sep 2024

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals